Emerging Trends in Medical Device Outsourcing and Contract Manufacturing PR Newswire MOUNTAIN VIEW, California, June 12, 2012 - The new medical device landscape: adapt or fade away MOUNTAIN VIEW, California, June 12, 2012 /PRNewswire/ -- WHEN: Starting 11:00 a.m. EDT on Thursday, June 14, 2012 LOCATION: Online, with complimentary registration KEYNOTE: Medical Devices Industry Manager Venkat Rajan for Frost & Sullivan's Healthcare Practice As part of the Patient Protection and Affordability Care Act (PPACA), a 2.3 percent excise tax goes into effect January 2013 on the sale of nearly all medical devices not sold direct to consumers. Though there are a number of legislative and other legal measures in play that could remove the provision before it goes in to effect, the potential of the tax has been identified as the trigger behind a number of significant organizational changes that have already taken place within many major medical devices companies. New business models and other healthcare cost containment pressures beyond the reform bill have forced companies to rethink their long term strategies and approach to product development. Frost & Sullivan's keynote presentation will take a look at the potential effects of those changing dynamics, and what it could mean long term for stakeholders across the supply chain of medical devices.